To evaluate the diagnostic potential of RNF41 methylation as a novel biomarker for HBV-related early cirrhosis, comprehensive Spearman correlation analyses were performed between RNF41 PMR levels and clinical parameters, including liver fibrosis indices, across CHB and HBV-CLC cohorts. The gene discussed is RNF41; the disease is Hepatic fibrosis.